Akorn, Inc.
- UEI
- N59RE1KDGAZ5
- CAGE
- 55751
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $10,225 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Alvogen, Inc. | Morristown, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Truax Patient Services, LLC | Bemidji, MN | 456110 Pharmacies and Drug Retailers |
| Indivior Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| FKA West-Ward Pharmaceuticals | Berkeley Heights, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Akorn, Inc. is a for-profit pharmaceutical manufacturer and distributor registered in SAM.gov since 2005. The company provides generic, specialty, branded, and over-the-counter pharmaceutical products to the federal government.
Akorn has been awarded numerous fixed price delivery orders as the prime contractor under an indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical to supply various dosages of naloxone injection solution. The delivery orders, valued between $83-498, require Akorn to deliver hundreds of thousands of dollars worth of naloxone injections for use as an opioid overdose reversal medication by military treatment facilities worldwide. By reliably supplying this critical pharmaceutical, Akorn directly aids DLA's stockpiling efforts to ensure deployed forces have rapid access to emergency overdose treatment.
Additionally, Akorn holds a $42 million single award indefinite delivery contract with DLA Troop Support Medical to procure pharmaceutical products in support of agency programs. Under this contract, Akorn has received fixed price delivery orders to supply naloxone injections to DLA's Lake Forest, Illinois facility by specified dates ranging from 2022 through 2023. As the contracted supplier of this product, Akorn helps the agency fulfill its mission to provision Class VIII medical supplies to all military treatment facilities.
Quick answers
Is Akorn, Inc. registered in SAM.gov?
Akorn, Inc.'s SAM.gov registration expired on February 2, 2023.
What is Akorn, Inc.'s CAGE code?
Akorn, Inc.'s CAGE code is 55751, and its Unique Entity ID (UEI) is N59RE1KDGAZ5.
Which contract vehicles does Akorn, Inc. hold?
Akorn, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Akorn, Inc. received in federal contracts?
Federal contracts obligated $10,225 to Akorn, Inc. in fiscal years 2023 through 2027.
What is Akorn, Inc.'s most recent federal award?
Akorn, Inc.'s most recent federal contract award is Naloxone 0.4 MG/ML injection solutionml (SPE2D323F4456), from Medical Supply Chain (DLA), on February 14, 2023.
On GovTribe
See Akorn, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors